Worldwide Healthcare Trust PLC
Worldwide Healthcare Trust PLC is a UK-based investment trust that focuses on healthcare-related assets, generating returns primarily through capital appreciation and income from its investment portfolio.
Business. Worldwide Healthcare Trust PLC is a UK-based investment trust that focuses on healthcare-related assets, generating returns primarily through capital appreciation and income from its investment portfolio.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Worldwide Healthcare Trust PLC is a UK-based investment trust that focuses on healthcare-related assets, generating returns primarily through capital appreciation and income from its investment portfolio.
Worldwide Healthcare Trust PLC exhibits a capital structure with a low debt-to-equity ratio of 0.04, indicating a conservative leverage position. The company's liquidity is assessed as medium, with a current ratio of 1.04, suggesting it has limited short-term liquidity cushion. The negative operating cash flow of -1.54 million GBP raises concerns about its ability to fund operations without external financing.
Profitability metrics are severely negative, with a return on equity of -12.49% and a return on assets of -11.81%. These figures are well below the typical performance of UK investment trusts, which usually aim for positive returns through effective portfolio management. The company's net income of -209.77 million GBP and operating income of -209.17 million GBP further underscore its financial distress.
The company's revenue is entirely derived from its investment portfolio, with no disclosed geographic or segment diversification. The negative revenue of -185.53 million GBP indicates a decline in the value of its investments or a reduction in income from its portfolio. There is no indication of geographic diversification, and the company's exposure is likely concentrated in the UK healthcare sector.
The company's growth trajectory is negative, with a substantial decline in revenue and profitability. The outlook for the current fiscal year is not provided, but the historical performance suggests a challenging environment. The company's operating cash flow and net income figures indicate a deteriorating financial position, with no clear signs of recovery in the near term.
Risk factors include medium liquidity risk and low dilution potential. The company's net cash is negative after subtracting total debt, which increases its vulnerability to short-term financial stress. The low dilution potential suggests that the company is not likely to issue additional shares in the near term, which could be a positive sign for existing shareholders.
Recent events include a significant decline in the company's financial performance, as reflected in its negative operating and net income. There are no recent filings or transcripts indicating strategic changes or new initiatives that could reverse the company's financial trajectory. The ESG scores suggest moderate social performance but weak governance, with a high ESG controversies score indicating potential reputational risks.
- The company is experiencing significant financial distress, with negative net income and operating income.
- The low debt-to-equity ratio suggests a conservative capital structure, but the negative operating cash flow raises liquidity concerns.
- The company's performance is well below the typical returns expected from UK investment trusts.
- The ESG scores indicate moderate social performance but weak governance and high controversy risk.
- There is no indication of geographic or segment diversification, and the company's exposure is likely concentrated in the UK healthcare sector.
- The company is unlikely to issue additional shares in the near term, which could be a positive sign for existing shareholders.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Return On Assetsnet_income / total_assets
- Worldwide Healthcare Trust PLC Market data — financials · 2026-05-30
- Worldwide Healthcare Trust PLC Market data — ESG · 2026-05-30